Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Translational medicine in action: anti-CD20 therapy in lymphoma.

Lim SH, Levy R.

J Immunol. 2014 Aug 15;193(4):1519-24. doi: 10.4049/jimmunol.1490027. Review.

2.

Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma.

Gadri Z, Kukulansky T, Bar-Or E, Haimovich J, Hollander N.

J Immunother. 2009 May;32(4):333-40. doi: 10.1097/CJI.0b013e31819b7c17.

PMID:
19342972
3.

Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma.

Betting DJ, Yamada RE, Kafi K, Said J, van Rooijen N, Timmerman JM.

J Immunother. 2009 Jul-Aug;32(6):622-31. doi: 10.1097/CJI.0b013e3181ab23f1.

PMID:
19483647
4.

Action and resistance of monoclonal CD20 antibodies therapy in B-cell Non-Hodgkin Lymphomas.

Pérez-Callejo D, González-Rincón J, Sánchez A, Provencio M, Sánchez-Beato M.

Cancer Treat Rev. 2015 Sep;41(8):680-9. doi: 10.1016/j.ctrv.2015.05.007. Epub 2015 May 19. Review.

PMID:
26045227
5.
6.

Characterization of a novel humanized anti-CD20 antibody with potent anti-tumor activity against non-Hodgkin's lymphoma.

Zhang H, Song L, Ye H, Hu L, Liang W, Liu D.

Cell Physiol Biochem. 2013;32(3):645-54. doi: 10.1159/000354468. Epub 2013 Sep 10.

7.

Rituximab resistance.

Rezvani AR, Maloney DG.

Best Pract Res Clin Haematol. 2011 Jun;24(2):203-16. doi: 10.1016/j.beha.2011.02.009. Epub 2011 Apr 13. Review.

8.

The future of CD20 monoclonal antibody therapy in B-cell malignancies.

Czuczman MS, Gregory SA.

Leuk Lymphoma. 2010 Jun;51(6):983-94. doi: 10.3109/10428191003717746. Review.

PMID:
20367564
9.

[Clinical observation of Rituximab in a CD20+B non-Hodgkin's lymphoma].

Hao LC, Zhang LZ.

Zhonghua Er Ke Za Zhi. 2003 Aug;41(8):627. Chinese. No abstract available.

PMID:
14744396
10.

[Rituximab, a chimeric anti-CD20 monoclonal antibody, in the treatment of B-cell lymphoma].

Tobinai K.

Gan To Kagaku Ryoho. 2002 Mar;29(3):473-80. Review. Japanese.

PMID:
11915743
11.

Improving therapeutic activity of anti-CD20 antibody therapy through immunomodulation in lymphoid malignancies.

Lipowska-Bhalla G, Fagnano E, Illidge TM, Cheadle EJ.

Leuk Lymphoma. 2016;57(6):1269-80. doi: 10.3109/10428194.2016.1157874. Epub 2016 Apr 6. Review.

PMID:
27050042
12.

[Resistance to rituximab and CD20 mutation].

Terui Y, Hatake K.

Nihon Rinsho. 2007 Jan 28;65 Suppl 1:416-23. Review. Japanese. No abstract available.

PMID:
17474440
13.
14.

The future of anti-CD20 monoclonal antibodies: are we making progress?

Alduaij W, Illidge TM.

Blood. 2011 Mar 17;117(11):2993-3001. doi: 10.1182/blood-2010-07-298356. Epub 2011 Jan 5.

15.

New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies.

Robak T, Robak E.

BioDrugs. 2011 Feb 1;25(1):13-25. doi: 10.2165/11539590-000000000-00000. Review.

PMID:
21090841
16.

Predictive significance of the cut-off value of CD20 expression in patients with B-cell lymphoma.

Horvat M, Kloboves Prevodnik V, Lavrencak J, Jezersek Novakovic B.

Oncol Rep. 2010 Oct;24(4):1101-7.

PMID:
20811695
17.

Ongoing development of monoclonal antibodies and antibody drug-conjugates in lymphoma.

Boyle EM, Morschhauser F.

Curr Oncol Rep. 2011 Oct;13(5):386-97. doi: 10.1007/s11912-011-0190-z.

PMID:
21845421
18.

Antibody therapy of lymphoma.

Illidge TM, Bayne MC.

Expert Opin Pharmacother. 2001 Jun;2(6):953-61. Review.

PMID:
11585011
19.

Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells.

Liu C, DeNardo G, Tobin E, DeNardo S.

Cancer Biother Radiopharm. 2004 Oct;19(5):545-61.

PMID:
15650447
20.

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies.

Alduaij W, Ivanov A, Honeychurch J, Cheadle EJ, Potluri S, Lim SH, Shimada K, Chan CH, Tutt A, Beers SA, Glennie MJ, Cragg MS, Illidge TM.

Blood. 2011 Apr 28;117(17):4519-29. doi: 10.1182/blood-2010-07-296913. Epub 2011 Mar 4.

Supplemental Content

Support Center